High-Dose Methotrexate as CNS Prophylaxis in High-Risk Aggressive B-Cell Lymphoma

Dr. Katharine Lewis Achieves Milestone: Publication in Prestigious Journal of Clinical Oncology

Dr. Kat Lewis Receives Cancer Council WA Early Career Researcher of the Year 2022

EVUSHELD & Patients with Blood Cancers

BCRWA @ The 63rd ASH Annual Meeting & Exposition 2021

Dr. Katharine Lewis to present Oral Abstract at ASH Annual Meeting 2021

Non-Covalent BTK Inhibitors—The New BTKids on the Block for B-Cell Malignancies

Pirtobrutinib results (formerly known as LOXO-305) published in The Lancet Journal